Thermo Fisher Scientific to Help Advance Myeloid Cancer Clinical Research and Treatment Utilizing Next Generation Sequencing Technology Life Science Investing
Thermo Fisher Scientific Completes Acquisition of Olink, Announces Commencement of Subsequent Offering Period Life Science Investing
First Patient Dosed with PD-L1 Nanobody in Phase 1 Therapeutic Non-Small Cell Lung Cancer Trial Biotech Investing
Olink Announces Receipt of CMA Clearance for Proposed Acquisition by Thermo Fisher Life Science Investing
